Skip to Main Content

Paper Details

Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.
Cancer Immunol Immunother
33
2019
Anti-CTLA4, B16 melanoma, B16F10, B16F10 melanomas, CD3, CD3+, CD3+ T-cell, CD47, CD47 m, CD47 mRNA, CD8, CD80, CD86, CTLA4, Cancer, Human, NK cells, NK-cell marker mRNA, T cells, T- and NK-cell, anti-CTLA4, cytotoxic T-cell, cytotoxic T-lymphocyte antigen-4, granzyme B, human, human T cells, interferon, irradiated melanoma cells, irradiated target cells, irradiated tumors, melanoma, mice, non-irradiated tumors, patients, tumor
Author NameAffiliation
Michael Allg??uerNational Cancer Institute
Zhiya YuCenter for Cancer Research, National Cancer Institute
Zhiya YuCenter for Cancer Research, National Cancer Institute
Nicholas P RestifoCenter for Cancer Research, National Cancer Institute
Nicholas P Restifo
Nicholas P RestifoCenter for Cancer Research, National Cancer Institute
Nicholas P Restifo
  • 1 - 7

Datasets

Release 1.2